桂林唇柱苣苔和百寿唇柱苣苔的开花动态及花粉活力和柱头可授性的比较

对桂林唇柱苣苔的两个居群(YZ居群和DB居群)和百寿唇柱苣苔的开花动态、花粉活力和柱头可授性进行了比较研究。结果表明,桂林唇柱苣苔的两个居群花期、单花持续期存在明显差异,DB居群的花期较YZ居群晚,但花期长于后者。YZ居群的花期、单花持续期与百寿唇柱苣苔的花期、单花持续期相近。三者开花过程相似。花粉活性和柱头可授性达最大的时间、持续时间在桂林唇柱苣苔的两个居群以及百寿唇柱苣苔之间具有明显差异。     

云南十种苦苣苔科植物的染色体数目报道

首次报道了产于云南的苦苣苔科Gesneriaceae2族7属10种植物的染色体数目。其中,1）芒毛苣苔属Aeschynanthus 2种：显苞芒毛苣苔A.bracteatus的染色体数目为2n=32,黄杨叶芒毛苣苔A.buxifolius2个居群的染色体数目不同,金平居群为2n=32,可能为二倍体,屏边居群的染色体数目为2n=64,可能为四倍体。2）吊石苣苔属Lysionotus 1种：吊石苣苔L.pauciflorus为2n=32。3）珊瑚苣苔属Corallodiscus 1种：石胆草 C.flabellatus的染色体数目为2n=40。4）唇柱苣苔属Chirita3种：圆叶唇柱苣苔Ch.dielsii,大叶唇柱苣苔Ch.macrophylla和美丽唇柱苣苔Ch.speciosa的染色体数目均为2n=18。5）半蒴苣苔属Hemiboea 1种：贵州半蒴苣苔H.cavaleriei为2n=32。6）马铃苣苔属Oreocharis 1种：黄马铃苣苔O.aurea为2n=34;7）石蝴蝶属Petrocosmea1种：髯毛胡蝶P.barbata为2n=32。     

中国广西石灰岩地区苦苣苔科一新种——鹿寨唇柱苣苔

描述了中国广西石灰岩地区苦苣苔科(Gesneriaceae)1新种--鹿寨唇柱苣苔(Chirita luzhaiensis Yah Lin,Y.S.Huang & W.B.Xu).该种与桂林唇柱苣苔(Chirita gueilinensis W.T.Wang)相似,但叶面被长柔毛和短柔毛,花药无毛,花丝近基部膝状弯曲,退化雄蕊3枚,无毛,花期12月至次年1月可与后者区别.目前,鹿寨唇柱苣苔仅见于广西鹿寨县中渡镇的两个石灰岩山洞中.     

广西苦苣苔科唇柱苣苔属一新种——李氏唇柱苣苔

报道了在广西柳州市市区附近一岩溶洞穴发现的苦苣苔科唇柱苣苔属一新种,并命名为李氏唇柱苣苔。本种与寿城唇柱苣苔及百寿唇柱苣苔相近,与寿城唇柱苣苔的主要区别在于植株体形、叶和花较大,叶为长卵状椭圆形或椭圆形,叶缘具锯齿,每花序1-3花,退化雄蕊3而与之不同;与百寿唇柱苣苔的区别主要在于叶缘具锯齿,每花序仅1-3花,花药背部密生紫色髯毛,退化雄蕊3而不同。     

广西苦苣苔科植物花粉形态

对广西苦苣苔科(Gesneriaceae)8个属(1个特有属)11个种(8个特有种)的花粉形态进行了扫描电镜的观察。结果发现这些不同属种的花粉形状均为长球形或近球形,花粉形状对苦苣苔科的系统与分类没有多大的参考价值。但花粉外壁纹饰则有多种类型。其中,吊石苣苔属(Lysionotus)、金盏苣苔属(I sometrum)、长檐苣苔属(Dolicholoma)、紫花苣苔属(Loxostigma)、半蒴苣苔属(Hemiboea)、圆唇苣苔属(Gy rocheilos)及唇柱苣苔属(Chirita)中的百寿唇柱苣苔(C.baishouensis)为网状纹饰;唇柱苣苔属(Chirita)的桂林唇柱苣苔(C.gueilinensis)和融安唇柱苣苔(C.ronganensis)为拟网状纹饰;异唇苣苔属(Allocheilos)为脑纹状纹饰。孢粉学特征表明,花粉外壁纹饰特征在苦苣苔科的分类与系统研究方面可能具有较大价值。     

一个孑遗类群——尖舌苣苔族（Klugieae）物种的居群绝灭速率及其指？…

本文通过对尖舌苣苔族（Ｋｌｕｇｉｅａｅ）的５个属中１２个种５９个地方居群消长动态的统计分析。计算了该族各属物种的居群绝灭速率,在１２０年的时间区间内,尖舌苣苔族物种的居群绝灭速率和生境受破坏程度呈正相关,显然,一个类群物种的居群绝灭速率对于该类群分布地区环境的受破坏程度具有较强的指示意义,尖舌苣苔族物种的居群绝灭速率与其系统发育年龄和进化程度密切相关,进行了水平较低,即系统发育上比较原始的类群,其     

桂林小花苣苔离体快速繁殖技术

对抗结核植物桂林小花苣苔（Chiritopsis repanda var.guilinensis）进行离体培养与快速繁殖技术研究。结果表明：桂林小花苣苔叶片外植体的最适初代诱导培养基为MS＋0.5mg·L^-16-BA＋0.05mg·L^-1IBA,pH8.0;最适继代增殖培养基为MS＋0.1mg·L^-16-BA＋0.05mg·L^-1IBA,pH6.0,繁殖系数7.0/35天;最适生根培养基为1/2MS＋0.2mg·L^-1NAA,pH6.0,生根率为93.6%。模拟桂林小花苣苔自然生境,在春季对生根试管苗进行大棚移栽,成活率达90%。根据上述快繁技术,理论上每株试管苗每年可繁殖桂林小花苣苔种苗46万株。     

桂林唇柱苣苔的组织培养和快速繁殖

1植物名称桂林唇柱苣苔（Chirita guilinensis W．T．Wang）。 2材料类别幼嫩叶片。 3培养条件（1）诱导培养基：MS＋6-BA0．2mg·L-1（单位下同）＋IBA0．1＋3％蔗糖;     

紫茎泽兰对五种苦苣苔科植物化感作用的初步研究

紫茎泽兰(Eupatorium adenophorum)为菊科一种入侵性极强的外来杂草,现已在我国西南部地区蔓延生长,并侵入多种苦苣苔科植物的生境。中国苦苣苔科植物均已收入《中国物种红色名录》,其中部分已被列为国家重点保护物种。为了解紫茎泽兰对本土苦苣苔科植物生长的影响,作者分别采用其根、茎、叶水提液(8%)对3属5种苦苣苔科植物,即刺齿唇柱苣苔(Chirita spinulosa)、荔波唇柱苣苔(C.liboensis)、烟叶唇柱苣苔(C.heterotricha)、芒毛苣苔(Aeschynanthus acuminatus)和台闽苣苔(Titanotrichum oldhamii)的幼苗进行处理。结果表明,紫茎泽兰叶水提液对刺齿唇柱苣苔、荔波唇柱苣苔和烟叶唇柱苣苔均有不同程度的化感作用,其中对刺齿唇柱苣苔的化感作用最为明显,当叶水提液在培养基中的浓度为2.4%、3.2%和4.0%时,刺齿唇柱苣苔幼苗的生长完全受到抑制。紫茎泽兰的茎水提液对台闽苣苔有一定程度的化感作用,当提取液在培养基中的浓度为1.6%时,对台闽苣苔幼苗生长的抑制效应达到40%。紫茎泽兰叶和茎水提液对芒毛苣苔幼苗生长无明显的化感作用,紫茎泽兰根水提液对5种苦苣苔科植物也均无显著影响。由此可知,紫茎泽兰对唇柱苣苔属和台闽苣苔属的植物有一定的化感作用,而对于芒毛苣苔属无明显的影响。分析结果显示,紫茎泽兰对岩生苦苣苔科种类要比附生于树上的近缘种化感作用更为明显。     

圆唇苣苔属(Gyrocheilos)花柱侧偏弯折现象及其传粉适应机制

圆唇苣苔属(Gyrocheilos)是苦苣苔科的中国特有属,有5种,全部狭域分布在我国西南及广东的高海拔山区。圆唇苣苔属所有物种的花柱侧偏且花柱顶端呈90°弯折,使得柱头位于花开口的中央位置。这种独特的侧偏弯折花柱结构,说明圆唇苣苔属可能有着特殊的演化历史和适应机制。为揭示这种特殊的花柱侧偏弯折现象的发生范围、发育过程及其传粉适应机制,该研究在圆唇苣苔(Gyrocheilos chorisepalus)、折毛圆唇苣苔(G. retrotrichus)和微毛圆唇苣苔(G. microtrichus)3个物种中开展了花部综合征观察,并研究了广东大雾岭保护区内的折毛圆唇苣苔花发育过程、花部特征和繁育系统以及传粉过程。结果表明:(1)微毛圆唇苣苔只有花柱左偏弯折现象,而圆唇苣苔和折毛圆唇苣苔虽然大部分花是花柱左偏弯折,但在部分个体中出现了少量的花柱右偏弯折现象(占种群总花数的2%～3%)。(2)传粉观察发现,折毛圆唇苣苔在花蕾期即出现了花柱弯折现象,2个可育雄蕊的花药合生、位于花冠筒喉部中央位置,与侧偏花柱不存在左右镜像对称关系。(3)折毛圆唇苣苔的花粉胚珠比(P/O)为456.98±15.55,属于兼性异交繁育系统。折毛圆唇苣苔存在一定的传粉限制,自交授粉可以结实,但异交种子萌发率更高,可能存在近交衰退。(4)折毛圆唇苣苔的访花昆虫较少,访花频率较低,主要访花昆虫有隧蜂、熊蜂、食蚜蝇等; 熊蜂体型较大,访花时降落在弯折花柱和花瓣下唇,胸部侧面及下部能有效接触到柱头。(5)反射率结果显示,折毛圆唇苣苔花瓣反射波长范围集中在紫光和蓝紫光区域,花冠的反射波长范围与蜂类视觉范围一致且花冠筒外侧和花瓣下唇的反射强度最大,更容易吸引蜂类落置在花冠宽大的下唇; 圆唇苣苔属的花柱侧偏弯折现象可能来自近缘的长蒴苣苔属(Didymocarpus)的花柱下弯现象或镜像花(mirror-image flowers)。综上认为,这种侧偏弯折的花柱,可能通过提供昆虫降落平台,使得柱头位于花开口中央和花瓣下唇的上方位置,提高了柱头接触访花昆虫的概率,是适应高海拔地区低频率访花者的一种机制。     

不同品系番茄对番茄刺皮瘿螨生长发育的影响

为了弄清楚不同番茄品种对番茄刺皮瘿螨Aculops lycopersici (Massee)的抗感性程度，通过田间调查、室内盆栽接螨和离体培养等方法，考察了12个番茄品种（系）（多茸毛类YZ618和YZ619；少茸毛类YZ419， YZ507和YZ504；野生品系YZ7和YZ5 叶黄类YZ401；常规品系YZ406，YZ412，YZ413和YZ515）上番茄刺皮瘿螨的种群发育情况。结果表明：番茄刺皮瘿螨在不同番茄品种（系）上的种群密度有明显差异，野生品系YZ7及多茸毛品系YZ618和YZ619上较低，少茸毛品系YZ504，YZ507和YZ419较高。不同番茄品种（系）可能是通过影响螨的存活率和产卵能力来影响在品种（系）上的种群发展。离体培养观察发现，番茄刺皮瘿螨的存活率在少茸毛品系YZ504和YZ507上最高，其次是品系YZ419，野生品系YZ7上最低。在YZ504上的产卵量最大，YZ419和YZ507次之，YZ7最小。根据实验种群参数判断，野生品系YZ7及多茸毛品系YZ618和YZ619感螨程度低，为抗性品系； 少茸毛品系YZ504，YZ419和YZ507感螨程度高，为感螨品系。     

Antagonistic Yeasts for Biocontrol of the Banana Postharvest Anthracnose Pathogen Colletotrichum musae

The biocontrol potentials of Candida tropicalis YZ1, C. tropicalis YZ27 and Saccharomyces cerevisiae YZ7 against the postharvest anthracnose pathogen Colletotrichum musae were investigated. Treatments with all the three biocontrol agents (1 × 10⁸ CFU/ml) significantly reduced the natural anthracnose disease severity of harvested banana fruits stored at ambient condition. Germination and survival of C. musae spores were markedly inhibited by all the three yeast strains in in vitro tests. The niche overlap index (NOI) was used to determine the interaction between the antagonists and C. musae, and the results (high NOI values) suggest competitive exclusion of C. musae by the yeast strains. C. tropicalis YZ27 inoculated on banana wounds exhibited rapid colonization and maintenance of its population on the inoculated site. The biocontrol efficacy was also observed as a function of concentration of the antagonist applied. The fruits treated with C. tropicalis YZ27, 36 h before pathogen inoculation, showed the best results with 96.0% disease inhibition followed by those treated 24 h before with 84.0% inhibition. The above results point to competition for nutrients and space as the main mechanism of antagonistic action of C. tropicalis YZ27 against C. musae.     

In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cells

The in vitro effects of 4 arylimidamides (DB811, DB786, DB750 and DB766) against the proliferative tachyzoite stage of the apicomplexan parasite Besnoitia besnoiti were investigated. These four compounds had been shown earlier to exhibit in vitro activities in the nanomolar range against the related apicomplexans Neospora caninum and Toxoplasma gondii. Real-time-PCR was used to assess B. besnoiti intracellular proliferation in vitro. Preliminary assessment by light microscopy identified DB811 and DB750 as the most promising compounds, while DB786 and DB766 were much less effective. Three-day-growth assays and quantitative real-time PCR was used for IC50 determination of DB811 (0.079 μM) and DB750 (0.56 μM). Complete growth inhibition was observed at 1.6 μM for DB 811 and 1.7 μM for DB750. However, when infected cultures were treated for 14 days, proliferation of parasites occurred again in cultures treated with DB750 from day 4 onwards, while the proliferation of DB811-treated tachyzoites remained inhibited. Electron microscopy of B. besnoiti-infected fibroblast cultures fixed and processed at different time-points following the initiation of drug treatments revealed that DB811 exerted a much higher degree of ultrastructural alterations compared to DB750. These results show that arylimidamides such as DB811 could potentially become an important addition to the anti-parasitic arsenal for food animal production, especially in cattle.     

CO2浓度升高对不同品种水稻镉吸收和根形态的影响

为了探讨CO2浓度升高下不同水稻品种荣优398 (RY)和粤杂889(YZ)吸收重金属Cd差异性的原因,利用水培试验研究了不同浓度Cd处理下两种水稻吸收Cd的差异及根形态的变化特征.结果表明:低Cd处理(5、10、20 μmol·L-1)显著增加水稻生物量;当Cd浓度高于50 μmol·L-1时,Cd胁迫效果开始显现,水稻生物量减少.CO2浓度升高显著增加了水稻的生物量,增加了YZ茎Cd含量而降低了RY茎Cd含量.在5～200 μmol·L-1的Cd浓度下,CO2浓度升高增加了YZ活性根在总根长中的比例,降低了RY活性根的比例.CO2浓度升高下不同水稻品种根形态的变化是导致其对Cd吸收差异性的原因之一.     

Chemotherapy of Second Stage Human African Trypanosomiasis: Comparison between the Parenteral Diamidine DB829 and Its Oral Prodrug DB868 in Vervet Monkeys

Human African trypanosomiasis (HAT, sleeping sickness) ranks among the most neglected tropical diseases based on limited availability of drugs that are safe and efficacious, particularly against the second stage (central nervous system [CNS]) of infection. In response to this largely unmet need for new treatments, the Consortium for Parasitic Drug Development developed novel parenteral diamidines and corresponding oral prodrugs that have shown cure of a murine model of second stage HAT. As a rationale for selection of one of these compounds for further development, the pharmacokinetics and efficacy of intramuscular (IM) active diamidine 2,5-bis(5-amidino-2-pyridyl)furan (DB829; CPD-0802) and oral prodrug2,5-bis[5-(N-methoxyamidino)-2-pyridyl]furan (DB868) were compared in the vervet monkey model of second stage HAT. Treatment was initiated 28 days post-infection of monkeys with T. b. rhodesiense KETRI 2537. Results showed that IM DB829 at 5 mg/kg/day for 5 consecutive days, 5 mg/kg/day every other day for 5 doses, or 2.5 mg/kg/day for 5 consecutive days cured all monkeys (5/5). Oral DB868 was less successful, with no cures (0/2) at 3 mg/kg/day for 10 days and cure rates of 1/4 at 10 mg/kg/day for 10 days and 20 mg/kg/day for 10 days; in total, only 2/10 monkeys were cured with DB868 dose regimens. The geometric mean plasma Cmax of IM DB829 at 5 mg/kg following the last of 5 doses was 25-fold greater than that after 10 daily oral doses of DB868 at 20 mg/kg. These data suggest that the active diamidine DB829, administered IM, should be considered for further development as a potential new treatment for second stage HAT.     

Effects of aromatic cationic molecules on bovine viral diarrhea virus and embryonic development

Bovine viral diarrhea virus (BVDV) has been shown to replicate in embryo culture systems and remain associated with bovine embryos developing in vitro. In this study, novel antiviral agents were evaluated for capability to inhibit replication of BVDV without affecting embryonic development. Serial concentrations of 2-[5(6)-{2-imidazolinyl}-2-benzimidazolyl]-5-(4-aminophenyl)furan (DB456) or 2-(4-[2-imidazolinyl]phenyl)-5-(4-methoxyphenyl)furan (DB606) were prepared in IVC medium. Then, bovine uterine tubal epithelial cells (UTC) were placed in IVC media with varying concentrations of DB456 or DB606. Within 1h, a genotype I or II strain of BVDV was added to the cultures. Cultures were maintained for 7 days. Infectious virus was quantitated in IVC media collected on days 3 and 7 and in UTC lysates harvested on day 7. The effective antiviral concentrations of DB606 were much lower than effective antiviral concentrations of DB456. In subsequent experiments, IVF presumptive zygotes were cultured in IVC medium with or without DB456 or DB606 at multiple concentrations for 7 days to evaluate effect of the compound on conceptus development. On day 7, stage of embryonic development was observed, and blastocysts were harvested and stained using Hoechst 33342 to enumerate embryonic cells. While DB456 inhibited blastocyst development, DB606 at 20 times the effective antiviral concentration did not hinder blastocyst development or reduce the mean number of cells per blastocyst. These preliminary results indicated that bovine embryo cultures might be safely supplemented with effective concentrations of an antiviral agent.     

pH值对萼花臂尾轮虫种群增长及繁殖的影响

采用种群积累培养法,实验观察了 ｐＨ在３．５～１１．５之间（间隔 １）萼花臂尾轮虫 （Ｂｒａｃｈｉｏｎｕｓ ｃａｌｙｃｉｆｌｏｒｕｓ）种群的增长及繁殖．结果表明,该轮虫种群在ＰＨ６．５～８．５之间增 长较快, ８． ５时增长最快,即瞬时增长率 ｒ和种群密度较大和最大; ｐＨ在 ３． ５～４． ５和 ９． ５ ～１０． ５之间,种群为负增长,即 ｒ为负值; ｐＨ在 ５． ５～９． ５之间种群为正增长,即正为正 值．该轮虫存活的ｐＨ上限为１１．５,下限为３．５．在种群增长最适ｐＨ（８．５）条件下,该轮虫 的繁殖最快,即绝对带卵量最高（１３２个·ｍｌ－１）;ｐＨ在９．５时,其相对带卵量最高．为其它 ｐＨ值条件下的２～４倍．本研究结果可为淡水轮虫的大批量培养提供可靠的ｐＨ值技术指 标．     

Safety,Pharmacokinetic, and Efficacy Studies of Oral DB868 in a First Stage Vervet Monkey Model of Human African Trypanosomiasis

There are no oral drugs for human African trypanosomiasis (HAT, sleeping sickness). A successful oral drug would have the potential to reduce or eliminate the need for patient hospitalization, thus reducing healthcare costs of HAT. The development of oral medications is a key objective of the Consortium for Parasitic Drug Development (CPDD). In this study, we investigated the safety, pharmacokinetics, and efficacy of a new orally administered CPDD diamidine prodrug, 2,5-bis[5-(N-methoxyamidino)-2-pyridyl]furan (DB868; CPD-007-10), in the vervet monkey model of first stage HAT. DB868 was well tolerated at a dose up to 30 mg/kg/day for 10 days, a cumulative dose of 300 mg/kg. Mean plasma levels of biomarkers indicative of liver injury (alanine aminotransferase, aspartate aminotransferase) were not significantly altered by drug administration. In addition, no kidney-mediated alterations in creatinine and urea concentrations were detected. Pharmacokinetic analysis of plasma confirmed that DB868 was orally available and was converted to the active compound DB829 in both uninfected and infected monkeys. Treatment of infected monkeys with DB868 began 7 days post-infection. In the infected monkeys, DB829 attained a median C_max (dosing regimen) that was 12-fold (3 mg/kg/day for 7 days), 15-fold (10 mg/kg/day for 7 days), and 31-fold (20 mg/kg/day for 5 days) greater than the IC₅₀ (14 nmol/L) against T. b. rhodesiense STIB900. DB868 cured all infected monkeys, even at the lowest dose tested. In conclusion, oral DB868 cured monkeys with first stage HAT at a cumulative dose 14-fold lower than the maximum tolerated dose and should be considered a lead preclinical candidate in efforts to develop a safe, short course (5–7 days), oral regimen for first stage HAT.     

Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis

Novel drugs to treat human African trypanosomiasis (HAT) are still urgently needed despite the recent addition of nifurtimox-eflornithine combination therapy (NECT) to WHO Model Lists of Essential Medicines against second stage HAT, where parasites have invaded the central nervous system (CNS). The pharmacology of a potential orally available lead compound, N-methoxy-6-{5-[4-(N-methoxyamidino) phenyl]-furan-2-yl}-nicotinamidine (DB844), was evaluated in a vervet monkey model of second stage HAT, following promising results in mice. DB844 was administered orally to vervet monkeys, beginning 28 days post infection (DPI) with Trypanosoma brucei rhodesiense KETRI 2537. DB844 was absorbed and converted to the active metabolite 6-[5-(4-phenylamidinophenyl)-furanyl-2-yl]-nicotinamide (DB820), exhibiting plasma C(max) values of 430 and 190 nM for DB844 and DB820, respectively, after the 14th dose at 6 mg/kg qd. A 100-fold reduction in blood trypanosome counts was observed within 24 h of the third dose and, at the end of treatment evaluation performed four days post the last drug dose, trypanosomes were not detected in the blood or cerebrospinal fluid of any monkey. However, some animals relapsed during the 300 days of post treatment monitoring, resulting in a cure rate of 3/8 (37.5%) and 3/7 (42.9%) for the 5 mg/kg×10 days and the 6 mg/kg×14 days dose regimens respectively. These DB844 efficacy data were an improvement compared with pentamidine and pafuramidine both of which were previously shown to be non-curative in this model of CNS stage HAT. These data show that synthesis of novel diamidines with improved activity against CNS-stage HAT was possible.